(2022)
Molecular profiling reveals characteristic and decisive signatures in patients after allogeneic stem cell transplantation suffering from invasive pulmonary aspergillosis.
J Fungi (Basel) 8(2),
171.
Prof. Dr. Gianni Panagiotou
Microbiome Dynamics · Leitung +49 3641 532-1759 gianni.panagiotou@leibniz-hki.deCurriculum vitae
Forschungsschwerpunkte
- Medizinische & Umweltmetagenomik: Mensch, Maus, Pflanzen, marine Lebewesen
- Systembiologie: Integration von –omics-Daten; Molekül/ Protein & Protein/ Protein Netzwerke
- Synthetische Biologie: Metabolische Modellierung auf Genomausmaß, Design von Probiotika, Entdeckung von Postbiotika
Publikationen
(2021)
Aspergillus fumigatus pan-genome analysis identifies genetic variants associated with human infection.
Nat Microbiol 6(12),
1526-1536.
(2021)
The peroxiredoxin asp f3 acts as redox sensor in Aspergillus fumigatus.
Genes 12(5),
668.
(2021)
Expansion and persistence of antibiotic-specific resistance genes following antibiotic treatment.
Gut Microbes 13(1),
1-19.
(2021)
Chronic occupational mold exposure drives expansion of Aspergillus-reactive type 1 and type 2 T-helper cell responses.
J Fungi 7(9),
698.
(2021)
DAnIEL: A user-friendly web server for fungal ITS amplicon sequencing data.
Front Microbiol 12,
720513.
(2021)
Gut microbiome functionality might be associated with exercise tolerance and recurrence of resected early-stage lung cancer patients.
PLOS One 16(11),
e0259898.
(2021)
An integrative understanding of the large metabolic shifts induced by antibiotics in critical illness.
Gut Microbes 13(1),
1993598.
(2021)
Metabolic modeling predicts specific gut bacteria as key determinants for Candida albicans colonization levels.
ISME J 15(5),
1257-1270.
(2021)
Distinct composition and metabolic functions of human gut microbiota are associated with cachexia in lung cancer patients.
ISME J 15(11),
3207-3220.
